Tirzepatide News | Live Feed & Top Stories

Tirzepatide

NBC Connecticut16:54Mounjaro FDA Pharma

Peoples Gazette02:38Mounjaro FDA Pharma

NPR13:10Mounjaro FDA Pharma

The Seattle Times18:29Mounjaro FDA Pharma

Men's Health18:17Ozempic Health Mounjaro

The Tribune, California16:56Ozempic Health Mounjaro

Quartz11:43Mounjaro Ozempic Pharma

The Motley Fool14:07Mounjaro Ozempic Pharma

Quartz05:01Ozempic Eli Lilly Mounjaro

Yahoo! UK & Ireland20:40Eli Lilly Novo Nordisk Laos

Yahoo! UK & Ireland20:06Eli Lilly Novo Nordisk Laos

News18.com02:03Eli Lilly Mounjaro Ozempic

The Conversation (UK)07:55Ozempic Global Health

Benzinga10:20Eli Lilly Mounjaro Obesity

pharmaphorum16:23Eli Lilly Mounjaro Obesity

ABC News15:34Mounjaro Obesity FDA

Yahoo! US15:13Mounjaro Obesity FDA

Latest News

In the last hour

UPI14:28

In the last 2 hours

NPR13:10

Earlier today

The Motley Fool06:47

Peoples Gazette02:38

Yesterday

Mint20:30 20-Dec-24

The Seattle Times18:29 20-Dec-24

Drug Topics17:55 20-Dec-24

Medpage Today17:50 20-Dec-24

TIME17:34 20-Dec-24

American Journal of Managed Care17:25 20-Dec-24

Pharmacy Times17:23 20-Dec-24

U.S. Food and Drug Administration (Press Release)17:07 20-Dec-24

NBC Connecticut16:54 20-Dec-24

PR Newswire (Press Release)16:37 20-Dec-24

U.S. Food and Drug Administration (Press Release)14:35 20-Dec-24

Pharmacy Times13:29 20-Dec-24

NewsNet5, Ohio12:03 20-Dec-24

Rock Hill Herald11:55 20-Dec-24

Clinical Trials Arena10:32 20-Dec-24

Zacks09:38 20-Dec-24

American Journal of Managed Care09:15 20-Dec-24

Pharmaceutical Technology08:18 20-Dec-24

The Conversation (UK)07:55 20-Dec-24

Benzinga07:19 20-Dec-24

GlobeNewswire (Press Release)05:50 20-Dec-24

Quartz05:01 20-Dec-24

Financial Mail04:41 20-Dec-24

In the last 7 days

Yahoo! UK & Ireland20:40 19-Dec-24

Yahoo! UK & Ireland20:06 19-Dec-24

Yahoo! UK & Ireland16:00 19-Dec-24

UPI15:49 19-Dec-24

ABC News15:34 19-Dec-24

FiercePharma15:26 19-Dec-24

Yahoo! US15:13 19-Dec-24

Medpage Today12:48 19-Dec-24

JD Supra12:46 19-Dec-24

TipRanks12:44 19-Dec-24

HealthDay12:31 19-Dec-24

Quartz11:43 19-Dec-24

BioPharma Dive11:41 19-Dec-24

PR Newswire (Press Release)11:14 19-Dec-24

ENDPOINTS10:42 19-Dec-24

The Hill10:35 19-Dec-24

The Hindu Business Line10:06 19-Dec-24

Bloomberg Law10:05 19-Dec-24

BNN Bloomberg09:58 19-Dec-24

pharmaphorum05:43 19-Dec-24

The Motley Fool04:52 19-Dec-24

Entrepreneur Magazine13:27 18-Dec-24

NTD News10:36 18-Dec-24

Pharmaceutical Field09:38 18-Dec-24

Pharmaceutical Technology07:07 18-Dec-24

The Motley Fool05:19 18-Dec-24

NBC Connecticut18:22 17-Dec-24

The Tribune, California16:56 17-Dec-24

U.S. Food and Drug Administration (Press Release)16:23 17-Dec-24

Zacks09:35 17-Dec-24

American Journal of Managed Care09:03 17-Dec-24

pharmaphorum08:19 17-Dec-24

Chemistry World Magazine04:30 17-Dec-24

News18.com02:03 17-Dec-24

Men's Health18:17 16-Dec-24

Business Wire (Press Release)05:09 16-Dec-24

News-Medical.Net03:58 16-Dec-24

HELLO!22:46 15-Dec-24

KCRG TV 9, Iowa22:24 15-Dec-24

MailOnline20:05 15-Dec-24

The Motley Fool14:07 15-Dec-24

The Motley Fool08:21 15-Dec-24

The Motley Fool07:40 15-Dec-24

The Motley Fool06:09 15-Dec-24

The Times of India13:24 14-Dec-24

In the last month

MailOnline20:38 13-Dec-24

NewsMax14:15 13-Dec-24

HealthDay12:40 13-Dec-24

Health Magazine12:10 13-Dec-24

American Journal of Managed Care11:17 13-Dec-24

The Mirror08:46 13-Dec-24

The Mirror06:26 13-Dec-24

GlobeNewswire (Press Release)17:08 12-Dec-24

Benzinga10:20 12-Dec-24

Pharmacy Times10:15 12-Dec-24

The Motley Fool07:55 12-Dec-24

UPI05:35 12-Dec-24

Eastern Daily Press, Norfolk01:50 12-Dec-24

pharmaphorum16:23 11-Dec-24

Medpage Today13:45 11-Dec-24

Newswise (Press Release)13:13 11-Dec-24

PR Newswire (Press Release)12:35 11-Dec-24

Yahoo! US09:54 11-Dec-24

Zacks09:09 11-Dec-24

PR Newswire (Press Release)08:03 11-Dec-24

Pharmafile01:00 11-Dec-24

Irish Examiner20:01 10-Dec-24

American Heart Association11:11 10-Dec-24

The Forester09:08 10-Dec-24

GlobeNewswire (Press Release)20:00 9-Dec-24

Longevity Technology17:16 9-Dec-24

Scrip Pharma Intelligence16:54 9-Dec-24

Longevity Technology12:56 9-Dec-24

KentLive10:29 9-Dec-24

Men's Health09:46 9-Dec-24

News Letter09:24 9-Dec-24

American Journal of Managed Care09:19 9-Dec-24

Clinical Trials Arena08:56 9-Dec-24

Benzinga08:27 9-Dec-24

pharmaphorum08:18 9-Dec-24

Benzinga07:46 9-Dec-24

Proactive Investors (UK)07:39 9-Dec-24

Benzinga06:17 9-Dec-24

The Economic Times06:17 9-Dec-24

pharmaphorum05:15 9-Dec-24

The Motley Fool05:00 9-Dec-24

view more headlines

21 Dec 14:28

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

쮸떴눈첵

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories